Novoheart Limited, provides, discovers and develops heart therapeutics. Novoheart's scientific team has pioneered a range of bioengineering technologies collectively known as the MyHeart platform, including first human mini-heart “novoHeart” that is capable of pumping and ejecting fluid.
TechnologiesAI Companies (Drug Discovery) Startups creating Artificial organs
Make sense of data from testing drug candidates on their bioartificial human heart constructs. Allows researchers to: More accurately evaluate a drug candidate's cardiac safety and effectiveness.
No pipelines published yet
No services posted yet